Looking to publish in Inflammopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowInflammopharmacology is a comprehensive resource on all aspects of inflammation and its pharmacological control, emphasizing pain therapy. It compares different inflammatory states and their causes, examines the actions, therapeutic efficacy and safety of drugs used in the treatment of inflammatory conditions, and covers Conditional Pharmacology/Toxicology, Rheumatology, Gastroenterology, Neuro-Inflammation, and Novel Drugs, Natural Products and Nutraceuticals, with particular emphasis on methods of measurement of clinical response effects of new agents and adverse effects from anti-rheumatic drugs, as well as the safety and efficacy of non-prescription and prescription NSAIDs and analgesics.
Looking to publish in Inflammopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Inflammopharmacology accepts the following article types. Click on an article type to view submission instructions.
Research
Reviews
Brief Report
Correspondence
Recent Publications
Kaempferol-loaded solid lipid nanoparticles attenuate cartilage degradation and inflammation by modulating the expression of pro and inflammatory cytokines, MMP-13 and oxidative stress markers in adjuvant induced arthritic rats
Anam Niamat, Aftab Ahmad, Nayla Munawar, Muhammad Shahid, Bushra Akhtar
Therapeutic update on alopecia areata: a critical review of standard and emerging targeted therapies
Francesco Ferrara
Neuroprotective role of cyanidin in Alzheimer’s and Parkinson’s disease: current insights and the road ahead
Bushra Bashir, Nandani Andotra, Prince Sharma, Tripti Sharma, Smriti Chauhan, Ankit Awasthi, Shareen Singh, Thakur Gurjeet Singh, Sachin Kumar Singh, Sukriti Vishwas
RGRN-305, a novel Hsp90 inhibitor: a promising therapeutic option for inflammatory dermatologic diseases
Nazila Heidari, Homayoun Pishraft-Sabet, Rayhaneh Gol, Dorsa Najari, Sara Eghbali, Amirhossein Heidari, Hamidreza Mahmoudi
Nature meets immunity: curcumin’s role in modulating neutrophil extracellular traps
Amirhossein Sahebkar, Elaheh Mirhadi, Tannaz Jamialahmadi, Sercan Karav, Prashant Kesharwani
Frequently asked questions
How long does it take to publish?
All manuscripts are reviewed anonymously by at least two independent reviewers. Articles are published online after receipt of the corrected proofs.
Reformat to Inflammopharmacology using Livewrite PremiumIs a cover letter required?
An accompanying letter submitted with the manuscript should state that the paper is original, unpublished, and not under consideration elsewhere. The corresponding author should mention unpublished material included in the manuscript in a cover letter to the editor.
Reformat to Inflammopharmacology using Livewrite PremiumWhat are the publication costs?
Open access APC: £3290.00 GBP / $5290.00 USD / €4090.00 EUR. Subscription publishing is available with no APC.
Reformat to Inflammopharmacology using Livewrite Premium